A case report of refractory pulmonary adenocarcinoma

Abstract

As one of the most common types of carcinomas, lung cancer has high incidence and mortality rates. Among the pathological types of lung cancer, pulmonary adenocarcinoma is the most prevalent. Advancements in medical treatments have contributed to improved prognosis in pulmonary adenocarcinomas. However, this case report revealed a rare refractory lung adenocarcinoma, suggesting that further research and robust management strategies are needed to improve clinical outcomes. In this regard, 18F-fluorodeoxyglucose positron emission tomography/ computed tomography plays a very important role in the comprehensive evaluation of glucose metabolic activity in lung adenocarcinoma and the progression of metastasis in distant organs.